Skip to main content
. Author manuscript; available in PMC: 2014 Nov 24.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Aug 4;(8):CD007701. doi: 10.1002/14651858.CD007701.pub2

Comparison 4.

Vaginal misoprostol 25 mcg versus 50 mcg

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Additional induction agents required (oxytocin) 1 49 Risk Ratio (M-H, Fixed, 95% CI) 2.26 [0.22, 23.33]
2 Uterine hyperstimulation 1 49 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
3 NICU admission 1 49 Risk Ratio (M-H, Fixed, 95% CI) 0.57 [0.05, 5.83]
4 Caesarean section 1 49 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.33, 2.68]
5 Interval from treatment to delivery (in days, all deliveries) 1 49 Mean Difference (IV, Fixed, 95% CI) 1.5 [1.19, 1.81]